CYTOO's News
Join us on LinkedIn
Discover our latest articles
🚀 Powering Precision: Functional Potency Assays by CYTOO
CYTOO develops functional potency assays to ensure batch consistency, biological activity, and regulatory compliance for gene therapies and biologics.
Revolutionizing Target Validation with Disease-Relevant Cellular Models
What’s the risk of using cellular models that lack disease-specific pathways for target validation❓
Need spatially organized cell cultures for your advanced cell-based assays?
Discover CYTOOchips™ – high-precision micropatterned coverslips that control cell shape, position, and organization for more reproducible and physiologically relevant results.
🧬 Finally, muscle disease models that actually predict clinical success.
CYTOO’s MyoScreen™ transforms real patient cells into powerful screening tools that actually predict therapeutic success.
💊 Small molecules, peptides, biologics…
💊 Small molecules, peptides, biologics… Whatever your compound class, CYTOO’s MyoScreen™ platform delivers reliable HIT IDENTIFICATION results for your next
New milestone in Pompe Disease modeling!
We’re excited to share our latest publication developing a muscle human model distinguishing late-onset from early-onset Pompe Disease in a